Market Cap : 9.78 B | Enterprise Value : 15.57 B | PE Ratio : At Loss | PB Ratio : 1.28 |
---|
NYSE:ELAN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:ELAN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Elanco Animal Health has the Growth Rank of 1.
GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:
1. 5-year revenue growth rate, the higher, the better.GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.
Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.
For the Drug Manufacturers - Specialty & Generic subindustry, Elanco Animal Health's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Elanco Animal Health's Growth Rank distribution charts can be found below:
* The bar in red indicates where Elanco Animal Health's Growth Rank falls into.
Thank you for viewing the detailed overview of Elanco Animal Health's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Meer James M | officer: Chief Accounting Officer | C/O ELANCO ANIMAL HEALTH, INC. 2500 INNOVATION WAY GREENFIELD IN 46140 |
Ehle Dirk | officer: Ex VP & Pres Elanco Europe | C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 |
Lee Joyce J. | officer: Ex VP Prs US Pet Hlth Com Op | C/O ZOETIS INC. 100 CAMPUS DRIVE FLORHAM PARK NJ 07940 |
Urbanek David Alan | officer: See Remarks | 2500 INNOVATION WAY GREENFIELD IN 46140 |
Schacht Aaron L | officer: See Remarks | 3750 BIRKDALE DR CARMEL IN 46033 |
Hoover R David | director, See Remarks | C/O EDGEWELL PERSONAL CARE COMPANY 1350 TIMBERLAKE MANOR PARKWAY CHESTERFIELD MO 63017 |
Bilbrey John P | director | PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"> Ownership Information: BILBREY JOHN P a.header:link {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:visited {color: #3b4fae; font-weight: bold; text-decoration: underline;} a.header:hover {color: #191970;} |
Garcia Art A | director | 11690 N.W. 105TH STREET MIAMI FL 33178 |
Young Todd S. | officer: See Remarks | C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 |
Bayer Aktiengesellschaft | 10 percent owner | BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368 |
Bayer World Investments B.v. | 10 percent owner | ENERGIEWEG 1 MIJDRECHT P7 3641 |
Mason Racquel Harris | officer: See Remarks | C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 |
Correia De Simas Jose Manuel | officer: See Remarks | C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 |
Harrington Michael J | director | LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 |
Anand Kapila K | director | C/O EXTENDED STAY AMERICA, INC. 11525 N. COMMUNITY HOUSE ROAD, SUITE 100 CHARLOTTE NC 28277 |
Other Sources
By Zacks 2021-05-21
By Zacks 2021-10-20
By Fool 2021-08-09
By Zacks 2021-07-30
By Zacks 2021-05-06
By Zacks 2021-11-05
By Seekingalpha 2022-02-24
By Zacks 2021-08-05